MARKET

CBPO

CBPO

China Biologic
NASDAQ

Real-time Quotes | Nasdaq Last Sale

118.40
0.00
0.00%
After Hours: 118.40 0 0.00% 16:08 01/26 EST
OPEN
118.42
PREV CLOSE
118.40
HIGH
118.70
LOW
118.05
VOLUME
146.15K
TURNOVER
--
52 WEEK HIGH
119.29
52 WEEK LOW
97.91
MARKET CAP
4.59B
P/E (TTM)
33.24
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
China Biologic Announces Extraordinary General Meeting Of Shareholders
China Biologic Announces Extraordinary General Meeting of Shareholders BEIJING, Jan. 25, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ:CBPO, ", , China Biologic", , or the ",
Benzinga · 1d ago
Fibrinogen Deficiency Drug Market Size 2021 Research Report by Share, Challenges, Trends, Geographical Regions, and Opportunities to 2027
Jan 21, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." “Fibrinogen Deficiency Drug Market” report...
The Express Wire · 5d ago
Plasma Protein Products Market Size, Analysis Top Countries In-Depth Research, Trends, Emerging Growth Factors and Regional Forecasts to 2025
Jan 21, 2021 (The Expresswire) -- "Global Plasma Protein Products Market"2021 project the value and sales volume of submarkets, with respect to key regions....
The Express Wire · 5d ago
Global Plasma Therapy Market 2021 - Demand in Market, Share, Size, Revenue, Growth Overview, Prospect, Top Leaders of Industry and Latest Trend
Jan 20, 2021 (The Expresswire) -- Global Plasma Therapy Market report would come handy to understand the competitors in the market and give an insight into...
The Express Wire · 6d ago
Blood Products Market 2021 : Revenue Data, Key Manufacturers, Historic and Forecast Analysis with Top Countries Data
Jan 19, 2021 (The Expresswire) -- Global “Blood Products Market" 2021-2026 Research Report provides key analysis on the market status of the Blood Products...
The Express Wire · 01/19 05:44
Global Poxviridae Infections Drug Market 2021 - Market Predicted to Grow at High CAGR, Complete Business Overview, Market Share, Size, Current Trends and Forecast to 2025
Jan 18, 2021 (The Expresswire) -- Global Poxviridae Infections Drug Market report would come handy to understand the competitors in the market and give an...
The Express Wire · 01/19 04:30
Protease Inhibitors Market Research Reports 2021 | Global Industry Share, Size, In-Depth Qualitative Insights, Top Leaders, Explosive Growth Opportunity, Emerging Factors, Regional Analysis by Market Reports World
Jan 11, 2021 (The Expresswire) -- Global “Protease Inhibitors Market” report studies the market in-depth and provides an all-encompassing analysis of the key...
The Express Wire · 01/11 09:32
Poxviridae Infections Drug Market Size, Share 2021 Industry Development Analysis, Global Trends, Growth Factors, CAGR Status, Industry Insights by Top Key Players and, Forecast to 2026 |Market Reports World
Jan 11, 2021 (The Expresswire) -- Global “Poxviridae Infections Drug Market” report provides industry Share, Size, CAGR, Production, Consumption, Revenue,...
The Express Wire · 01/11 09:32
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CBPO. Analyze the recent business situations of China Biologic through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CBPO stock price target is 102.78 with a high estimate of 119.00 and a low estimate of 77.00.
EPS
Institutional Holdings
Institutions: 140
Institutional Holdings: 14.57M
% Owned: 37.56%
Shares Outstanding: 38.79M
TypeInstitutionsShares
Increased
32
946.68K
New
32
160.44K
Decreased
30
414.38K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-1.91%
Pharmaceuticals & Medical Research
-0.64%
Key Executives
Chairman/Chief Executive Officer/Director
Joseph Chow
Chief Financial Officer
Ming Yang
Director
Hui Li
Director
Yue'e Zhang
Independent Director
Yungang Lu
Independent Director
Qi Ning
Independent Director
Sean Shao
Independent Director
Xiaosheng Shao
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
About CBPO
China Biologic Products Holdings, Inc. is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates through the manufacture and sales of human plasma products segment. China Biologic has a product portfolio with over 20 various dosage forms of plasma products and other biopharmaceutical products across nine categories.The Company's products include human albumin, human immunoglobulin, immunoglobulin for intravenous injection (IVIG), human hepatitis B immunoglobulin, human rabies immunoglobulin, human tetanus immunoglobulin, placenta polypeptide, Factor VIII and human prothrombin complex concentrate (PCC).

Webull offers kinds of China Biologic Products Holdings Inc stock information, including NASDAQ:CBPO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CBPO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CBPO stock methods without spending real money on the virtual paper trading platform.